Personal tools

MCL coexpression mm9:1455: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000160!7.70e-13!31;UBERON:0005409!8.99e-10!47;UBERON:0003914!6.10e-09!47;UBERON:0009854!5.95e-08!23;UBERON:0009856!5.95e-08!23;UBERON:0000344!1.13e-07!15;UBERON:0002365!1.63e-07!25;UBERON:0002330!1.63e-07!25;UBERON:0002107!1.90e-07!22;UBERON:0007499!1.90e-07!22;UBERON:0006925!1.90e-07!22;UBERON:0009497!1.90e-07!22;UBERON:0000015!1.90e-07!22;UBERON:0002423!1.90e-07!22;UBERON:0006235!1.90e-07!22;UBERON:0008835!1.90e-07!22;UBERON:0003894!1.90e-07!22;UBERON:0004161!1.90e-07!22;UBERON:0008836!1.90e-07!22;UBERON:0001242!8.62e-07!13;UBERON:0000060!8.62e-07!13;UBERON:0001262!8.62e-07!13;UBERON:0004786!8.62e-07!13
|ontology_enrichment_uberon=UBERON:0000160!7.70e-13!31;UBERON:0005409!8.99e-10!47;UBERON:0003914!6.10e-09!47;UBERON:0009854!5.95e-08!23;UBERON:0009856!5.95e-08!23;UBERON:0000344!1.13e-07!15;UBERON:0002365!1.63e-07!25;UBERON:0002330!1.63e-07!25;UBERON:0002107!1.90e-07!22;UBERON:0007499!1.90e-07!22;UBERON:0006925!1.90e-07!22;UBERON:0009497!1.90e-07!22;UBERON:0000015!1.90e-07!22;UBERON:0002423!1.90e-07!22;UBERON:0006235!1.90e-07!22;UBERON:0008835!1.90e-07!22;UBERON:0003894!1.90e-07!22;UBERON:0004161!1.90e-07!22;UBERON:0008836!1.90e-07!22;UBERON:0001242!8.62e-07!13;UBERON:0000060!8.62e-07!13;UBERON:0001262!8.62e-07!13;UBERON:0004786!8.62e-07!13
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.473747,0.464605,0.535892,0.346849,0.550971,0.645383,0.691572,0.257202,0.0835344,0.599767,0.632897,0.247704,0.6581,0.364314,0,0.856992,0.338549,0.656199,0.442204,0.426133,1.17476,1.58083,0.345236,0.472505,0.686615,0.63639,0.572827,0.394364,0.534301,0.558142,0.960397,0.892985,0.204204,4.55385,0.951637,0.326478,0.629145,1.48701,0.27383,0.907317,0.56353,0.327433,0.959963,2.48719,1.30113,0.77511,0.589246,0.284064,0.397446,0.839084,0.714419,0.174327,1.10437,1.12205,0.66551,1.04848,0.619643,0.614918,0.663395,0.939962,0.724164,0.269393,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.253541,0.11437,1.156,0.208101,1.08629,0.204132,0.763395,0.922432,1.10012,0.254777,0.874787,0.722675,0.240896,1.03903,0.768392,0.0610418,0.181203,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.281222,0.685716,0.976308,0.775372,0.938145,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,0.484547,1.0885,1.10269,0.605144,1.33732,2.45028,0.0704207,0.53982,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,0.679647,1.35909,0.347287,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,1.38533,0.778321,2.10357,0.503174,0.348692,0.540361,0.667976,1.10596,0.783181,1.62569,1.18867,0.71546,0.376898,0.48935,1.25034,1.31911,2.36367,0.926663,0.482185,0.82857,0.671017,0.325308,0.63125,0.5667
}}
}}

Revision as of 19:56, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr3:130974927..130974991,-p1@Hadh
Mm9::chr3:130974995..130974996,-p2@Hadh
Mm9::chr4:107596084..107596100,-p2@Cpt2
Mm9::chr4:107596113..107596122,-p3@Cpt2
Mm9::chr4:107596124..107596220,-p1@Cpt2
Mm9::chr9:108564430..108564550,+p1@Slc25a20


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005739mitochondrion0.00335232242348332
GO:0006631fatty acid metabolic process0.00335232242348332
GO:0032787monocarboxylic acid metabolic process0.00335232242348332
GO:0005743mitochondrial inner membrane0.00335232242348332
GO:0019866organelle inner membrane0.00335232242348332
GO:0031966mitochondrial membrane0.00335232242348332
GO:0005740mitochondrial envelope0.00335232242348332
GO:0004095carnitine O-palmitoyltransferase activity0.00335232242348332
GO:00038573-hydroxyacyl-CoA dehydrogenase activity0.00335232242348332
GO:0016416O-palmitoyltransferase activity0.00335232242348332
GO:0044429mitochondrial part0.00410810615792097
GO:0016406carnitine O-acyltransferase activity0.0041899438406562
GO:0031975envelope0.00453799157182207
GO:0031967organelle envelope0.00453799157182207
GO:0019752carboxylic acid metabolic process0.00565429891753072
GO:0006082organic acid metabolic process0.00565429891753072
GO:0044255cellular lipid metabolic process0.00661243880005698
GO:0031090organelle membrane0.00661243880005698
GO:0016409palmitoyltransferase activity0.00661243880005698
GO:0006629lipid metabolic process0.007600041905139
GO:0044444cytoplasmic part0.0114105288159519
GO:0008374O-acyltransferase activity0.0114120987087785
GO:0016616oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor0.0396417957725654
GO:0050662coenzyme binding0.0396417957725654
GO:0016614oxidoreductase activity, acting on CH-OH group of donors0.0396417957725654
GO:0005737cytoplasm0.0483821185722341
GO:0048037cofactor binding0.0489670450367433
GO:0008415acyltransferase activity0.0489670450367433
GO:0016747transferase activity, transferring groups other than amino-acyl groups0.0489670450367433
GO:0016746transferase activity, transferring acyl groups0.0492535389499352



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
intestine7.70e-1331
gastrointestinal system8.99e-1047
epithelial tube6.10e-0947
digestive tract diverticulum5.95e-0823
sac5.95e-0823
mucosa1.13e-0715
exocrine gland1.63e-0725
exocrine system1.63e-0725
liver1.90e-0722
epithelial sac1.90e-0722
digestive gland1.90e-0722
epithelium of foregut-midgut junction1.90e-0722
anatomical boundary1.90e-0722
hepatobiliary system1.90e-0722
foregut-midgut junction1.90e-0722
hepatic diverticulum1.90e-0722
liver primordium1.90e-0722
septum transversum1.90e-0722
liver bud1.90e-0722
intestinal mucosa8.62e-0713
anatomical wall8.62e-0713
wall of intestine8.62e-0713
gastrointestinal system mucosa8.62e-0713


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}